Management of Mixed-Phenotype Acute Leukemia in the East of France

Brief Title

Management of Mixed-Phenotype Acute Leukemia in the East of France

Official Title

Management of Mixed-Phenotype Acute Leukemia in the East of France

Brief Summary

      Clinical presentation and management of Mixed-Phenotype Acute leukemia (MPAL) is
      heterogeneous. This descriptive observationnal study aims to review MPAL cases in the East of
      France based on a 10-year multicentre retrospective collection.
    



Study Type

Observational


Primary Outcome

Age of the patients when diagnosed with MPAL

Secondary Outcome

 Date of every relapse for each patient

Condition

Mixed Phenotype Acute Leukemia



Publications

* Includes publications given by the data provider as well as publications identified by National Clinical Trials Identifier (NCT ID) in Medline.

Recruitment Information



Estimated Enrollment

70

Start Date

September 2018

Completion Date

June 2019

Primary Completion Date

June 2019

Eligibility Criteria

        Inclusion Criteria:

          -  Adult patients over 18 years of age

          -  Diagnosis of biphenotypic acute leukemia or mixed-phenotype acute leukemia between
             2008 and 2018
      

Gender

All

Ages

18 Years - N/A

Accepts Healthy Volunteers

No

Contacts

, , 



Administrative Informations


NCT ID

NCT03599869

Organization ID

PSS2017/ELABEST-BONMATI/VS


Responsible Party

Sponsor

Study Sponsor

Central Hospital, Nancy, France


Study Sponsor

, , 


Verification Date

July 2018